Back to first-pass browser

First-pass extracted concept

Mucinous ovarian carcinoma

Candidate: concept label1 source documents5 linked claims
Jump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

MOC

Evidence Snippets

Mucinous ovarian carcinoma (MOC) represents a rare and biologically distinct subtype of ovarian cancer
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1challengesupports2025Source 1DOIPubMed

Intratumoral heterogeneity and therapy resistance remain challenges in mucinous ovarian carcinoma.

Claim 2clinical strategy needsupports2025Source 1DOIPubMed

Mucinous ovarian carcinoma needs innovative clinical trial designs and combination regimens.

Claim 3disease characterizationsupports2025Source 1DOIPubMed

Mucinous ovarian carcinoma is a rare and biologically distinct subtype of ovarian cancer.

Claim 4molecular profilesupports2025Source 1DOIPubMed

Mucinous ovarian carcinoma frequently shows KRAS mutations and HER2 amplifications.

Claim 5treatment responsesupports2025Source 1DOIPubMed

Mucinous ovarian carcinoma responds poorly to standard platinum-based chemotherapy.